Corruption Risks in Pharma Manufacturing in Russia

Published date25 July 2014
Law FirmMichael Volkov
Subject MatterCompliance,Economic Development,FCPA,Pharmaceutical Industry,Risk Assessment,Russia,UK Bribery Act

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT